Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1664-5553|4|2|115-125

ISSN： 2235-1795

Source： Liver Cancer, Vol.4, Iss.2, 2015-04, pp. : 115-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis

By  

Digestion, Vol. 83, Iss. 4, 2011-02 ,pp. : 275-282

Karger

Access to resources Recommend Favorite

Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 3, Iss. 2, 2014-05 ,pp. : 108-118

Karger

Access to resources Recommend Favorite

Liver Transplantation for Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 2, Iss. 3-4, 2013-08 ,pp. : 338-344

Karger

Access to resources Recommend Favorite

High Hepatitis B Virus DNA Level in Serum before Liver Transplantation Increases the Risk of Hepatocellular Carcinoma Recurrence

By  

Digestion, Vol. 84, Iss. 2, 2011-04 ,pp. : 134-141

Karger

Access to resources Recommend Favorite

Radiologic Complete Response with Sirolimus and Sorafenib in a Hepatocellular Carcinoma Patient who Relapsed After Orthotopic Liver Transplantation

By Kim Richard  

Journal of Gastrointestinal Cancer, Vol. 42, Iss. 1, 2011-03 ,pp. : 50-53

Springer Publishing Company

Access to resources Recommend Favorite